[1]
A. E. . Arcellana, “THE USE OF MULTIMODALITY TREATMENT FOR AN ATYPICAL, RECURRENT AND AGGRESSIVE MEDULLARY THYROID CANCER”, J ASEAN Fed Endocr Soc, vol. 36, p. 4, Jul. 2021.